[1] Brinton LA, Nasca PC, Mallin K, et al. Case-control study of cancer of the vulva. Obstet Gynecol, 1990, 75:859-866. [2] Tamakoshi K, Kikkawa F, Nawa A, et al. Characterization of extracellular matrix-degrading proteinase and its inhibitor in gynecologic cancer tissues with clinically different metastatic form. Cancer, 1995,76:2565-2571. [3] Varani J, Hattori Y, Chi Y, et al. Collagenolytic and gelatinolytic matrix metalloproteinases and their inhibitors in basal cell carcinoma of skin:comparison with normal skin. Br J Cancer, 2000, 82:657-665. [4] 樊翌明,李慧忠,吴志华,等.基质金属蛋白酶10、金属蛋白酶组织抑制因子2等在皮肤鳞状细胞癌中的表达.中华皮肤科杂志,2002,35:396-398. [5] Al-Ghamdi A, Freedman D, Miller D, et al. Vulvar squamous cell carcinoma in young women:a clinicopathologic study of 21 cases.Gynecol Oncol, 2002, 84:94-101. [6] Kagie MJ, Kenter GG, Tollenaar RA, et al. p53 protein overexpression is common and independent of human papillomavirus infection in squamous cell carcinoma of the vulva. Cancer, 1997, 80:1228-1233. [7] Ngan HY, Cheung AN, Liu SS, et al. Abnormal expression or mutation of TP53 and HPV in vulvar cancer. Eur J Cancer, 1999, 35:481-484. [8] Della Torre G, Donghi R, Longoni A, et al. HPV DNA in intraepithelial neoplasia and carcinoma of the vulva and penis. Diagn Mol Pathol, 1992, 1:25-30. |